Lopadine Sterile Eye Drops: Each ml contains 1.11 mg Olopatadine Hydrochloride USP equivalent to Olopatadine 1 mg.
Lopadine DS Sterile Eye Drops: Each ml contains 2.22 mg of Olopatadine Hydrochloride USP equivalent to Olopatadine 2mg.
Olopatadine is an inhibitor of the release of histamine from the mast cell and a relatively selective histamine H1 -antagonist that inhibits histamine induced inflammatory effects on human conjunctival epithelial cells.
Olopatadine is indicated for the treatment of ocular itching associated with allergic conjunctivitis.
Lopadine: Adults and children (above 3 years of age). One drop of Lopadine in the conjunctival sac of the affected eye(s) twice daily.
Lopadine DS: Adults and children (above 2 years of age). One drop in each affected eye once a day.
Ocular: blurred vision, burning or stinging, conjunctivitis, dry eye, foreign body sensation, hyperemia, hypersensitivity, keratitis, lid edema, pain and ocular pruritus.
Non-ocular: asthenia, back pain, flu syndrome, headache, increased cough, infection, nausea, rhinitis, sinusitis and taste perversion.
To prevent contaminating the dropper tip and solution, care should be taken not to touch the eyelids or surrounding areas with the dropper tip of the bottle. Patients should be advised not to wear a contact lens if their eye is red. Lopadine should not be used to treat contact lens related irritation.
Pregnancy category C. There is no adequate and well- controlled studies in pregnant women. Therefore, this drug should be used in pregnant women only if the potential benefit to the mother justifies the potential risk to the embryo or fetus.
It is not known if this medicine passes into breast milk, therefore it is not recommended for use during breastfeeding.